Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

MacroGenics Inc. (MGNX)

25.43   0.4 (1.6%) 09-29 01:24
Open: 25.28 Pre. Close: 25.03
High: 25.85 Low: 24.9
Volume: 326,379 Market Cap: 1,376M
MacroGenics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing antibody-based therapeutics designed to modulate the human immune response for the treatment of cancer. The company is headquartered in Rockville, Maryland and currently employs 364 full-time employees. The firm develops therapeutic product candidates using its antibody-based technology platforms and also in collaboration with other biopharmaceutical companies. The company has a pipeline of product candidates in human clinical testing, primarily as treatments for different types of cancers, which are created using its technology platforms. Its clinical product candidate, margetuximab, has been enhanced using its Fc Optimization platform. The firm is also developing several product candidates targeting B7-H3, a protein in the B7 family of immune regulator proteins. The firm's product candidates also include enoblituzumab and MGD009, MGC018, MGD006 (flotetuzumab), MGD007, MGD011 (duvortuxizumab), PF-06671008 and MGD010.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 25.894 - 26.018 26.018 - 26.13
Low: 24.597 - 24.74 24.74 - 24.87
Close: 25.194 - 25.429 25.429 - 25.644

Technical analysis

as of: 2020-09-28 4:35:04 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 33.73     One year: 37.39
Support: Support1: 23.81    Support2: 19.81
Resistance: Resistance1: 28.88    Resistance2: 32.01
Pivot: 27.30
Moving Average: MA(5): 25.13     MA(20): 27.19
MA(100): 26.13     MA(250): 15.90
MACD: MACD(12,26): -0.36     Signal(9): 0.05
Stochastic oscillator: %K(14,3): 15.17     %D(3): 12.04
RSI: RSI(14): 43.73
52-week: High: 32.18  Low: 4.04  Change(%): 111.6
Average Vol(K): 3-Month: 53108  10-Days: 82065

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
MGNX has closed above bottom band by 27.7%. Bollinger Bands are 8.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 23 Sep 2020
MacroGenics Announces MGC018 Publication in Molecular Cancer Therapeutics - GlobeNewswire

Mon, 21 Sep 2020
MacroGenics Inc. (MGNX) Plunges 12.91% on September 21 -

Fri, 18 Sep 2020
MacroGenics Inc. (MGNX) 14-day ATR is 1.89: This Stock is Set to Soar Above its Peers - News Daemon

Thu, 17 Sep 2020
MacroGenics Inc. (MGNX) Soars 8.44% on September 17 -

Thu, 17 Sep 2020
$15.11 Million in Sales Expected for MacroGenics Inc (NASDAQ:MGNX) This Quarter - MarketBeat

Mon, 14 Sep 2020
Is MacroGenics Inc (MGNX) A Winner in the Healthcare Sector? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 54
Shares Float (M) 44
% Held by Insiders 7.42
% Held by Institutions 94.18
Shares Short (K) 3,690
Shares Short P. Month (K) 4,160

Stock Financials

EPS -3.380
EPS Est This Year -4.410
EPS Est Next Year -3.980
Book Value (p.s.) 4.640
Profit Margin -213.99
Operating Margin -217.48
Return on Assets (ttm) -29.8
Return on Equity (ttm) -61.5
Qtrly Rev. Growth 91.2
Gross Profit (p.s.) -2.424
Sales Per Share 1.440
EBITDA (p.s.) -2.932
Qtrly Earnings Growth
Operating Cash Flow (M) -136
Levered Free Cash Flow (M) -94

Stock Valuations

PE Ratio -7.52
PEG Ratio
Price to Book value 5.48
Price to Sales 17.66
Price to Cash Flow -10.11

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.